Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Chanson

Showing results (311-320 of 363) with videos related to

Pageof 37
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experienceGérald Raverot, Nathalie Sturm, Florence de Fraipont, et al.
Journal of Hepatology|August 13, 2011
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activationJean Charles Nault, Monique Fabre, Gabrielle Couchy, et al.
European Journal of Endocrinology|September 16, 2022
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Chiara Villa, Thomas Cuny, et al.
Clinical Endocrinology|March 26, 2018
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYNElena Valassi, Richard Feelders, Dominique Maiter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in FranceAlexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, et al.
Annales D'Endocrinologie|July 31, 2018
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusionsFrédéric Castinetti, Frédéric Albarel, Françoise Archambeaud, et al.
European Journal of Endocrinology|July 18, 2012
Cardiovascular findings and management in Turner syndrome: insights from a French cohortBruno Donadille, Alexandra Rousseau, Delphine Zenaty, et al.
European Journal of Endocrinology|October 12, 2021
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort studyMaelle Le Bras, Hélène Leclerc, Olivia Rousseau, et al.
European Journal of Endocrinology|December 25, 2014
Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective studyDelphine Vezzosi, Catherine Cardot-Bauters, Nicolas Bouscaren, et al.
The British Journal of Surgery|July 14, 2022
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort studySébastien Gaujoux, Guillaume L Martin, Eric Mirallié, et al.
Pageof 37

Showing results (311-320 of 363) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experienceGérald Raverot, Nathalie Sturm, Florence de Fraipont, et al.
Journal of Hepatology|August 13, 2011
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activationJean Charles Nault, Monique Fabre, Gabrielle Couchy, et al.
European Journal of Endocrinology|September 16, 2022
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Chiara Villa, Thomas Cuny, et al.
Clinical Endocrinology|March 26, 2018
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYNElena Valassi, Richard Feelders, Dominique Maiter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 5, 2022
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in FranceAlexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, et al.
Annales D'Endocrinologie|July 31, 2018
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusionsFrédéric Castinetti, Frédéric Albarel, Françoise Archambeaud, et al.
European Journal of Endocrinology|July 18, 2012
Cardiovascular findings and management in Turner syndrome: insights from a French cohortBruno Donadille, Alexandra Rousseau, Delphine Zenaty, et al.
European Journal of Endocrinology|October 12, 2021
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort studyMaelle Le Bras, Hélène Leclerc, Olivia Rousseau, et al.
European Journal of Endocrinology|December 25, 2014
Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective studyDelphine Vezzosi, Catherine Cardot-Bauters, Nicolas Bouscaren, et al.
The British Journal of Surgery|July 14, 2022
Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort studySébastien Gaujoux, Guillaume L Martin, Eric Mirallié, et al.
Pageof 37